The PDUFA action date for an FDA decision for linvoseltamab to treat adult patients with relapsed/refractory multiple myeloma ...
Black Americans have double the risk of developing multiple myeloma compared to white Americans and are diagnosed at younger ages.
Multiple myeloma is a rare type of blood cancer that forms in plasma cells, a white blood cell that makes antibodies and helps you fight infection. The cancer occurs when the plasma cells inside ...
Opna Bio, a clinical-stage biopharmaceutical company focused on the discovery and development of novel oncology therapeutics, announced today that the FDA has granted orphan drug designation (ODD) to ...
The future is bright for our bone marrow transplant program,” Dr. Hana Safah said. "We look forward to advancing blood cancer ...
The future is bright for our bone marrow transplant program,” Dr. Hana Safah said. "We look forward to advancing blood cancer ...
Dana-Farber Cancer Institute researchers will present key research studies at the 2025 Tandem Meetings, the premier ...
Dana-Farber Cancer Institute researchers will present key research studies at the 2025 Tandem Meetings, the premier conference in hematopoietic cell transplantation (HCT) and cellular therapy.
Patients with multiple myeloma (MM) can experience diminished ... bolster immunity in this vulnerable population. The 66th American Society of Hematology (ASH) Annual Meeting & Exposition took ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback